Secukinumab monoclonal antibody drug. Targets interleukin-17A (IL-17A) and is used in treatment of psoriasis. Generic name and stylized antibody.

---

Size: 9000px × 4551px
Photo credit: © molekuul.be / Alamy / Afripics
License: Royalty Free
Model Released: No

Keywords: ankylosing, antibody, biological, biosimilar, biotech, biotechnology, cytokine, dermatologic, dermatology, disease, drug, il-17a, immunoglobulin, immunology, inflammation, infusion, injection, inn, interleukin, interleukin-17a, keratinocyte, lymphocytes, mab, monoclonal, nomenclature, peptide, protein, psoriasis, secukinumab, spondylitis